1)メタボリックシンドローム診断基準検討委員会:メタボリックシンドロームの定義と診断基準.日内誌94:794-809, 2005
2)Grundy SM, et al:Definition of metabolic syndrome:Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438, 2004
3)Alberti KGMM, et al:Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;National Heart, Lung, and Blood Institute;American Heart Association;World Heart Federation;International Atherosclerosis Society;and International Association for the Study of Obesity. Circulation 120:1640-1645, 2009
4)Kadota A, et al:Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity:NIPPON DATA90, 1990-2000. Diabetes Care 30:1533-1538, 2007
5)Ohashi Y, et al:[Association of obesity and other cardiovascular risk factors with stroke the Japan Arteriosclerosis Longitudinal Study--Existing Cohorts Combined(JALS-ECC)]. Nihon Koshu Eisei Zasshi 58:1007-1015, 2011
6)Chei C, et al:Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke among Middle-Aged Japanese. Hypertens Res 31:1887-1894, 2008
7)Noda H, et al:The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke:the Japan public health center-based study. Hypertens Res 32:289-298, 2009
8)Kobayashi J, et al:Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria. Circ J 71:1734-1737, 2007
9)Doi Y, et al:Proposed criteria for metabolic syndrome in Japanese based on prospective evidence:the Hisayama study. Stroke 40:1187-1194, 2009
10)Kokubo Y, et al:Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population:the suita study. Hypertens Res 31:2027-2035, 2008
11)Arai H, et al:Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb 13:202-208, 2006
12)厚生労働省:国民健康・栄養調査.https://www.mhlw.go.jp/bunya/kenkou/kenkou_eiyou_chousa.html
13)Saito I, et al:Metabolic syndrome and all-cause and cardiovascular disease mortality:Japan Public Health Center-based Prospective(JPHC)Study. Circ J 73:878-884, 2009
14)Takashima N, et al:Population attributable fraction of smoking and metabolic syndrome on cardiovascular disease mortality in Japan:a 15-year follow up of NIPPON DATA90. BMC Public Health 10:306, 2010
15)Imamura T, et al:LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population:the Hisayama study. Stroke 40:382-388, 2009
16)Satoh M, et al:Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death:Evidence for Cardiovascular Prevention from Observational Cohorts in Japan. Hypertension 65:517-524, 2015
17)Nakamura K, et al:Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke:pooled analysis of 10 Japanese cohort studies. Cerebrovasc Dis 33:480-491, 2012
18)日本動脈硬化学会(編):動脈硬化性疾患予防ガイドライン 2017年版.日本動脈硬化学会,2017
19)日本高血圧学会高血圧治療ガイドライン作成委員会(編):高血圧治療ガイドライン2014.日本高血圧学会,2014
20)厚生労働省:健康日本21(第二次).https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/kenkounippon21.html
21)厚生科学審議会地域保健健康増進栄養部会,次期国民健康づくり運動プラン策定専門委員会:健康日本21(第二次)の推進に関する参考資料.https://www.mhlw.go.jp/bunya/kenkou/dl/kenkounippon21_02.pdf